BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26096645)

  • 1. Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance.
    Wang Z; Ma R; Yan L; Chen X; Zhu G
    Chem Commun (Camb); 2015 Jul; 51(58):11587-90. PubMed ID: 26096645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance.
    Zhang W; Shen J; Su H; Mu G; Sun JH; Tan CP; Liang XJ; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13332-40. PubMed ID: 27164222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells.
    Yuan Y; Zhang CJ; Liu B
    Chem Commun (Camb); 2015 May; 51(41):8626-9. PubMed ID: 25898264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A facile strategy to generate polymeric nanoparticles for synergistic chemo-photodynamic therapy.
    Deng X; Liang Y; Peng X; Su T; Luo S; Cao J; Gu Z; He B
    Chem Commun (Camb); 2015 Mar; 51(20):4271-4. PubMed ID: 25673062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Layered double hydroxide nanosheets: towards ultrasensitive tumor microenvironment responsive synergistic therapy.
    Yan L; Wang Y; Hu T; Mei X; Zhao X; Bian Y; Jin L; Liang R; Weng X; Wei M
    J Mater Chem B; 2020 Feb; 8(7):1445-1455. PubMed ID: 31993613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilic polyphosphoester-conjugated fluorinated chlorin as an entirely biodegradable nano-photosensitizer for reliable and efficient photodynamic therapy.
    Liu Z; Wu M; Xue Y; Chen C; Wurm FR; Lan M; Zhang W
    Chem Commun (Camb); 2020 Feb; 56(16):2415-2418. PubMed ID: 31994584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells.
    Zhang W; Li Y; Sun JH; Tan CP; Ji LN; Mao ZW
    Chem Commun (Camb); 2015 Feb; 51(10):1807-10. PubMed ID: 25493294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
    ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor.
    Xu S; Zhu X; Zhang C; Huang W; Zhou Y; Yan D
    Nat Commun; 2018 May; 9(1):2053. PubMed ID: 29795534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
    Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical antagonism between photodynamic agents and chemotherapeutics: mechanism and avoidance.
    Meng Q; Meng J; Ran W; Su J; Yang Y; Zhang P; Li Y
    Chem Commun (Camb); 2017 Nov; 53(92):12438-12441. PubMed ID: 29099532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.
    Roby A; Erdogan S; Torchilin VP
    Eur J Pharm Biopharm; 2006 Apr; 62(3):235-40. PubMed ID: 16326084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance.
    Gao Y; Jiang M; Ma Y; Wu S; Li W; Yang X; Li Y; Jing X; Jiang H
    Anticancer Drugs; 2016 Feb; 27(2):77-83. PubMed ID: 26473527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintillator-Based Nanohybrids with Sacrificial Electron Prodrug for Enhanced X-ray-Induced Photodynamic Therapy.
    Wang H; Lv B; Tang Z; Zhang M; Ge W; Liu Y; He X; Zhao K; Zheng X; He M; Bu W
    Nano Lett; 2018 Sep; 18(9):5768-5774. PubMed ID: 30052464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of low doses cisplatin synergistic effect on photodynamic outcome of aluminum phythalocyanine on soft tissue sarcoma (RD) cell line.
    Ali S; Khurshid A; Maqsood M; Rafi M; Khan JA; Zaidi SS; Mohammad S; Ikram M
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):146-9. PubMed ID: 25562442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance.
    Song H; Li W; Qi R; Yan L; Jing X; Zheng M; Xiao H
    Chem Commun (Camb); 2015 Jul; 51(57):11493-5. PubMed ID: 26094840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(iv) anticancer prodrugs - hypotheses and facts.
    Gibson D
    Dalton Trans; 2016 Aug; 45(33):12983-91. PubMed ID: 27214873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.